Biohaven Ltd. (BHVN)
Last updated: 2026-11-05 22:04:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Biohaven Ltd. (BHVN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $13.88, with a market capitalization of $2.36B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $7.48 to $18.24. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$2.36B | |
$15.11 | |
$152.56 | |
$7.10 | |
$15.24 | |
2.95M | |
3.20M | |
-- | |
$18.24 | |
$7.48 | |
-- | |
-- |
Biohaven Ltd. (BHVN) After-Hours Stock Price
Biohaven Ltd. (BHVN) is trading at $13.67 in after-hours trading as of 2026-11-05 22:03:00, down 10.33% ($1.57) from the regular-session close of $15.24.
After-hours trading shows how investors are pricing BHVN after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Biohaven Ltd. (BHVN) 7-Day Stock Price Change
Over the past seven days, Biohaven Ltd. (BHVN) moved from $15.29 to $13.88, representing a decline of 9.23% ($1.41).
The stock traded between $13.84 and $16.49 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.50 million shares, down versus the previous seven-day period, indicating lower trading activity.
BHVN 52-Week Price Position
Position in Range: 59.5%
BHVN is currently trading at $13.88, placing it 59.5% of the way from its 52-week low of $7.48 to its 52-week high of $18.24. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Biohaven Ltd. (BHVN)?
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Biohaven Ltd. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 274 |
| Exchange | NYSE |
| Company Website |
How to Buy Biohaven Ltd. (BHVN) Stock on MEXC
Eligible investors can buy real shares of Biohaven Ltd. (BHVN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Biohaven Ltd. (BHVN) stock price today?
2.Is BHVN stock going up or down today?
3.What is BHVN pre-market price?
4.What is BHVN after-hours price?
5.Is BHVN stock trading now?
6.Where does BHVN sit relative to its 52-week high and low?
7.What sector is Biohaven Ltd. in?
8.What is Biohaven Ltd.'s market capitalization and where is it listed?
9.How is BHVN valued in terms of P/E ratio and EPS?
10.Does Biohaven Ltd. pay a dividend?
Explore More US Stocks
Search Stocks
BHVN Stock Calculator
Estimate the value between BHVN shares and USD.
BHVN Shares to USD
1.00 BHVN shares = 13.878 USD
Calculations are estimates based on the latest available price and are for reference only.




